MAIER PAUL V
SEC CIK 1182615 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | Dir | 72.2K | — | $5.91M | 4 | 2026-08-28 | 2026-08-28 |
Most active insiders at ETON, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BRYNJELSEN SEAN | Pres, CEO, Dir, 10% | — | $9.91M |
| 2 | Opaleye Management Inc. | 10% | — | $6.89M |
| 3 | MAIER PAUL V | Dir | — | $5.91M |
| 4 | Krempa David | Chief Business Off | — | $4.86M |
| 5 | Adams Jennifer McKie | Dir | — | $1.62M |
| 6 | Erdogan-Trinkaus Ipek | Chief Commercial Off | — | — |
| 7 | Gruber James R. | CFO | — | — |
| 8 | RIEDEL NORBERT G | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMA | 2026-08-31 16:06 | 2026-08-28 | ETON | Eton Pharmaceuticals, Inc. | MAIER PAUL V | Dir | M - OptEx | $4.49 | +62.5K | 72.2K | +641% | +$280.4K |
| DMA | 2026-08-31 16:06 | 2026-08-28 | ETON | Eton Pharmaceuticals, Inc. | MAIER PAUL V | Dir | S - Sale+OE | $59.07 | -50.0K | 59.7K | -46% | -$2.95M |
| D | 2026-08-28 16:51 | 2026-08-28 | ETON | Eton Pharmaceuticals, Inc. | MAIER PAUL V | Dir | M - OptEx | $3.78 | +50.0K | 109.7K | +84% | +$189.0K |
| DM | 2026-08-28 16:51 | 2026-08-28 | ETON | Eton Pharmaceuticals, Inc. | MAIER PAUL V | Dir | S - Sale+OE | $59.07 | -50.0K | 59.7K | -46% | -$2.95M |
Purchase Sale Sale after option exercise All abbreviations